Asian Journal of Social Pharmacy ›› 2020, Vol. 15 ›› Issue (3): 153-158.

Previous Articles     Next Articles

Research on Marketing Strategies of Product D — a Chronic Myelogenous Leukemia Drug for Pharmaceutical Company A

Gu Pu, Wei Tingting, Wu Zhi’ang*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2020-09-20 Published:2020-09-15
  • Contact: Wu Zhi’ang, professor. Major research area: pharmaceutical regulations and drug policies, etc. Tel: 18611552403, E-mail: 13940328503@139.com. E-mail:13940328503@139.com

Abstract: Objective To put forward some suggestions on the marketing strategies for chronic myelogenous leukemia in a pharmaceutical enterprise. Methods Based on the development status of the pharmaceutical industry and the SWOT analysis of a company’s product, the marketing strategies were formulated to provide theoretical basis for pharmaceutical enterprise to adapt to the new medical reform. Results and Conclusion Nowadays, due to fierce competition, in order to expand the new market, enterprises should implement the strategies of new products, centralized management and professional training. Meanwhile, the effective marketing strategies should be formulated and strictly carried out according to the conditions of the pharmaceutical company.

Key words: pharmaceutical company, chronic myelogenous leukemia, marketing strategy, economic benefit

Trendmd